NAMS
NewAmsterdam Pharma Company N.V.
23.20$
-4.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1.3% | 98.5% | 99.9% | 99.9% | 99.9% | 87.8% | |
| 1.0% | 88.8% | 97.7% | 98.1% | 89.3% | 63.7% | |
| 1.0% | 88.8% | 97.7% | 98.1% | 96.5% | 82.7% | |
| – | 8.1% | 0.4% | 0.5% | 2.5% | 3.0% | |
| – | 0.0% | 0.0% | -0.5% | – | – | |
| 0.0% | 0.3% | – | – | – | – | |
| – | – | 0.0% | – | – | – | |
| – | – | 0.0% | 0.0% | 0.1% | 0.1% | |
| 8.9% | 16.7% | 10.1% | 16.9% | 12.4% | 11.2% | |
| 0.2% | 16.5% | 7.5% | 14.4% | 12.4% | 11.2% | |
| 8.3% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 0.1% | 10.4% | 2.5% | 4.9% | 0.5% | 1.2% | |
| 91.1% | 83.3% | 89.9% | 83.1% | 87.6% | 88.8% | |
| 0.0% | -58.0% | -29.3% | -91.3% | -64.6% | -99.1% | |
| 12.7% | 26.1% | 4.0% | 23.7% | 10.9% | 14.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.